Snowball logo
logo
29A

Amphastar Pharmaceuticals Inc

€26.56€0.00  (0%)
Estimate
P/E
18.3
EPS
1.45
Beta
0.503
Growth
Revenue, YoY
8.26%
Net income, YoY
0.42%
FCF, YoY
92.63%
About the company
Ticker
29A
ISIN
US03209R1032
Country
Other
Sector (GICS)
Other

Frequently asked questions

What sector does Amphastar Pharmaceuticals Inc (29A) operate in?

Amphastar Pharmaceuticals Inc belongs to the Other sector.

What is Amphastar Pharmaceuticals Inc (29A) current stock price?

As of the latest data, Amphastar Pharmaceuticals Inc stock price is €26.56, with a previous close of €26.56.

What is Amphastar Pharmaceuticals Inc (29A) Earnings Per Share (EPS)?

The trailing EPS is €1.45.

What is Amphastar Pharmaceuticals Inc (29A) Price-to-Earnings (P/E) ratio?

Amphastar Pharmaceuticals Inc current P/E ratio is 18.32.

What is Amphastar Pharmaceuticals Inc (29A) EBITDA?

Amphastar Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 53.99 million.

Does Amphastar Pharmaceuticals Inc (29A) pay dividends?

No. Amphastar Pharmaceuticals Inc does not pay a dividend.

When is Amphastar Pharmaceuticals Inc (29A) next earnings report?

Amphastar Pharmaceuticals Inc is expected to release its next earnings report on September 30, 2026.

What is Amphastar Pharmaceuticals Inc (29A) beta (volatility) score?

Amphastar Pharmaceuticals Inc has a beta of 0.503, indicating lower volatility than the overall market.